54 213 54 213 Pill - white capsule/oblong, 12mm
Pill with imprint 54 213 54 213 is White, Capsule/Oblong and has been identified as Lithium Carbonate 150 mg. It is supplied by Hikma Pharmaceuticals PLC.
Lithium is used in the treatment of Bipolar Disorder; Schizoaffective Disorder; Mania and belongs to the drug class antimanic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 54 213 54 213
Lithium Carbonate
- Imprint
- 54 213 54 213
- Strength
- 150 mg
- Color
- White
- Size
- 12.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antimanic agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Hikma Pharmaceuticals PLC
- Inactive Ingredients
-
FD&C Red No. 40,
sodium lauryl sulfate,
magnesium silicate,
titanium dioxide,
ferrosoferric oxide,
povidone k30,
shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00054-8526 | Roxane Laboratories, Inc. |
| 00054-2526 | Roxane Laboratories, Inc. |
More about lithium
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (485)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: antimanic agents
- Breastfeeding
- En español
Patient resources
- Lithium drug information
- Lithium Capsules and Tablets
- Lithium Controlled-Release and Extended-Release Tablets
- Lithium Syrup and Oral Solution
Other brands
Eskalith, Lithobid, Eskalith-CR
Professional resources
- Lithium monograph
- Lithium (FDA)
- Lithium Capsules (FDA)
- Lithium Carbonate (FDA)
- Lithium Carbonate ER Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.